Predicting rTMS Treatment Success for Depression Using Brain Connectivity
While repetitive transcranial magnetic stimulation (rTMS) is an effective therapy for TRD, it’s difficult to predict which patients will benefit most. To address this, finding biological markers (biomarkers) that can predict treatment response is a crucial goal for providing personalized care. This study used resting-state functional magnetic resonance imaging (fMRI) to explore brain activity patterns, aiming to discover neuroimaging biomarkers that can distinguish patients who will respond to rTMS from those who won’t.